NGENF Nervgen Consolidation continues Possible entry aheadNice long ~2 year consolidation is in progress, recent reject from the top side of wedge will present entry opportunities
Entry target ~ 1.15-1.35 (1.25 average)
Interesting medical treatments currently in trials
Long term play
